Detailed information for compound 2142717

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 460.087 | Formula: C23H17ClN6OS
  • H donors: 3 H acceptors: 2 LogP: 5.22 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: Clc1cccc(c1)Nc1nccc2c1ccc(c2N=C(c1csc2c1nc[nH]c2=N)O)C
  • InChi: InChI=1S/C23H17ClN6OS/c1-12-5-6-16-15(7-8-26-22(16)29-14-4-2-3-13(24)9-14)18(12)30-23(31)17-10-32-20-19(17)27-11-28-21(20)25/h2-11H,1H3,(H,26,29)(H,30,31)(H2,25,27,28)
  • InChiKey: RFEWCQAWLXXDQI-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens colony stimulating factor 1 receptor No references
Homo sapiens discoidin domain receptor tyrosine kinase 2 No references
Homo sapiens Raf-1 proto-oncogene, serine/threonine kinase No references
Homo sapiens discoidin domain receptor tyrosine kinase 1 No references
Homo sapiens B-Raf proto-oncogene, serine/threonine kinase No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Loa Loa (eye worm) TKL/RAF/RAF protein kinase Get druggable targets OG5_130459 All targets in OG5_130459
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_130314 All targets in OG5_130314
Echinococcus granulosus discoidin domain receptor Get druggable targets OG5_130314 All targets in OG5_130314
Loa Loa (eye worm) raf kinase Get druggable targets OG5_130459 All targets in OG5_130459
Echinococcus granulosus raf serine:threonine protein kinase Get druggable targets OG5_130459 All targets in OG5_130459
Schistosoma japonicum ko:K04365 B-Raf proto-oncogene serine/threonine-protein kinase, putative Get druggable targets OG5_130459 All targets in OG5_130459
Brugia malayi Raf kinase Get druggable targets OG5_130459 All targets in OG5_130459
Echinococcus multilocularis raf serine:threonine protein kinase Get druggable targets OG5_130459 All targets in OG5_130459
Onchocerca volvulus Get druggable targets OG5_130314 All targets in OG5_130314
Schistosoma mansoni serine/threonine protein kinase Get druggable targets OG5_130459 All targets in OG5_130459
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_130314 All targets in OG5_130314
Brugia malayi Protein kinase domain containing protein Get druggable targets OG5_130314 All targets in OG5_130314
Echinococcus granulosus macrophage colony stimulating factor 1 receptor Get druggable targets OG5_132967 All targets in OG5_132967
Loa Loa (eye worm) TK/DDR protein kinase Get druggable targets OG5_130314 All targets in OG5_130314

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Plasmodium falciparum LCCL domain-containing protein 0.0033 0.018 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.018 0.5
Echinococcus granulosus macrophage colony stimulating factor 1 receptor 0.0506 0.9588 0.958
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.018 0.5
Loa Loa (eye worm) TKL/RAF/RAF protein kinase 0.03 0.5487 0.5548
Plasmodium vivax LCCL domain-containing protein 0.0033 0.018 0.5
Loa Loa (eye worm) hypothetical protein 0.0033 0.018 0.0182
Plasmodium vivax LCCL domain-containing protein 0.0033 0.018 0.5
Loa Loa (eye worm) hypothetical protein 0.0033 0.018 0.0182
Toxoplasma gondii F5/8 type C domain-containing protein 0.0033 0.018 0.5
Toxoplasma gondii F5/8 type C domain-containing protein 0.0033 0.018 0.5
Toxoplasma gondii F5/8 type C domain-containing protein 0.0033 0.018 0.5
Echinococcus granulosus discoidin domain receptor 0.0265 0.4794 0.4699
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.018 0.5
Trichomonas vaginalis beta-hexosaminidase B, putative 0.0033 0.018 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.018 0.5
Mycobacterium tuberculosis Possible arabinofuranosyltransferase AftD 0.0033 0.018 0.5
Schistosoma mansoni serine/threonine protein kinase 0.0526 1 1
Trichomonas vaginalis hypothetical protein 0.0033 0.018 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.018 0.5
Trichomonas vaginalis alpha-L-fucosidase, putative 0.0033 0.018 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.018 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.018 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.018 0.5
Onchocerca volvulus 0.027 0.4904 1
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.018 0.5
Toxoplasma gondii PA14 domain-containing protein 0.0033 0.018 0.5
Loa Loa (eye worm) hypothetical protein 0.0265 0.4794 0.4848
Loa Loa (eye worm) raf kinase 0.0521 0.989 1
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.018 0.5
Brugia malayi Raf kinase 0.0508 0.9637 1
Mycobacterium leprae PROBABLE CONSERVED TRANSMEMBRANE PROTEIN 0.0033 0.018 0.5
Brugia malayi Protein kinase domain containing protein 0.027 0.4904 0.5089
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.018 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.018 0.5
Plasmodium falciparum LCCL domain-containing protein 0.0033 0.018 0.5
Loa Loa (eye worm) hypothetical protein 0.0237 0.4243 0.4291
Loa Loa (eye worm) TK/DDR protein kinase 0.0237 0.4243 0.4291
Echinococcus multilocularis raf serine:threonine protein kinase 0.0526 1 1
Trichomonas vaginalis alpha-L-fucosidase, putative 0.0033 0.018 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.018 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.018 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0033 0.018 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 5 nM Kinase Activity BINDINGDB. No reference
IC50 (binding) = 9 nM Kinase Activity BINDINGDB. No reference
IC50 (binding) = 40 nM Kinase Activity BINDINGDB. No reference
IC50 (binding) = 57 nM Kinase Activity BINDINGDB. No reference
IC50 (binding) = 66 nM Kinase Activity BINDINGDB. No reference
IC50 (binding) = 93 nM Kinase Activity BINDINGDB. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.